Global Allergy Diagnostics Market to Reach US$5.7 Billion by the Year 2026

ReportLinker

Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares. - Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, May 11, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Allergy Diagnostics Industry" - https://www.reportlinker.com/p05797875/?utm_source=GNW
- Online interactive peer-to-peer collaborative bespoke updates
- Access to our digital archives and MarketGlass Research Platform
- Complimentary updates for one year
- Global Allergy Diagnostics Market to Reach US$5.7 Billion by the Year 2026

- Allergy represents a medical condition characterized by exaggerated or abnormal response of the immune system to harmless substances or allergens, causing signs like skin irritation, itchiness, swelling, red eyes, hay-fever, anaphylaxis or asthma attack. There are different types of allergies, including skin and dust allergy, drug allergy, food allergy, and insect stings allergy. There are different types of blood and skin tests that help healthcare providers in detecting an allergy. The diagnosis defines the nature of allergic condition along with the treatment course. The global allergy diagnostics market, after decelerating for a while owing to the Covid-19 effect, is back up and growing, led by increasing cases of allergy resulting from exposure to pollution, and increased consumption of processed food as well as dairy and confectionary products. The growing prevalence of allergy and associated health implications warrants a pressing need for effective diagnosis and treatment. The rapidly increasing incidence of allergy coupled with changing dietary habits is playing a pivotal role in bolstering the allergy diagnostics market. The market growth is also augmented by increasing level of environmental pollution and the resulting increase in the number of individuals suffering from allergic conditions. Changing lifestyles and dietary patterns coupled with rapid urbanization and increasing level of outdoor and indoor pollution are likely to increase the incidence of allergic conditions. The market growth is estimated to be also propelled by strong demand for in-vitro diagnostic blood tests.

- Amid the COVID-19 crisis, the global market for Allergy Diagnostics estimated at US$3.8 Billion in the year 2022, is projected to reach a revised size of US$5.7 Billion by 2026, growing at a CAGR of 9.3% over the analysis period. Assay Kits, one of the segments analyzed in the report, is projected to grow at a 10% CAGR to reach US$3.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 9.2% CAGR for the next 7-year period. This segment currently accounts for a 28.2% share of the global Allergy Diagnostics market. Assay kits are anticipated to witness high demand fueled by key factors such as rising preference for assay kits by medical practitioners in allergy testing, high prevalence of allergic diseases, and increasing test volumes. The high product availability and need for repeat purchase in allergy testing is also expected to drive high consumption of assay kits in the coming years. Despite the high cost of instruments, the segment is forecast to hold a significant share due to the long lifespan of instruments and limited need for frequent installations. The procurement of used instruments by smaller healthcare organizations also expands market share for instruments. The U.S. Market is Estimated at $1.3 Billion in 2022, While China is Forecast to Reach $622.5 Million by 2026

- The Allergy Diagnostics market in the U.S. is estimated at US$1.3 Billion in the year 2022. The country currently accounts for a 34.21% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$622.5 Million in the year 2026 trailing a CAGR of 13.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.1% and 8.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR while Rest of European market (as defined in the study) will reach US$189.6 Million by the end of the analysis period. Although developed regions constitute major revenue contributors, developing regions have emerged as hot spots for future growth of allergy diagnostics market. Factors such as increasing public and private sector investments in healthcare domain, rising incidence of allergies, and improvement in healthcare access and rising awareness levels, are favoring market growth in the developing regions.
- Services Segment to Reach $1.1 Billion by 2026

- In the global Services segment, USA, Canada, Japan, China and Europe will drive the 7.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$544.4 Million will reach a projected size of US$872.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$124.1 Million by the year 2026, while Latin America will expand at a 9.6% CAGR through the analysis period. Select Competitors (Total 100 Featured) Alk-Abelló A/S Allergy Therapeutics PLC ALPCO Angsana Molecular & Diagnostics Laboratory Pte. Ltd. Astra Biotech GmbH biomérieux SA Demeditec Diagnostics GmbH EUROIMMUN Medizinische Labordiagnostika AG GA Generic Assays GmbH INDOOR Biotechnologies, Inc. Lincoln Diagnostics, Inc. Omega Diagnostics Group Plc R-Biopharm Ag Roxall Medizin GmbH Siemens Healthineers Stallergenes Greer Tecan Trading AG Theradiag Thermo Fisher Scientific Inc.


Read the full report: https://www.reportlinker.com/p05797875/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Allergens: A Prelude
Key Allergy Stats
Allergy: Symptoms and Causes
Allergic Diagnostics: An Introduction
Food Allergen Testing
Impact of Covid-19 and a Looming Global Recession
The Never-Ending ?Race? Between the Virus & Vaccines Continues.
Amidst this Chaotic Battle, Where is the World Economy Heading
Now & Beyond?
Omicron Variant Brings Back Memories & Fears of the Worst Part
of the 2020 Pandemic
EXHIBIT 1: Time is of Essence! What We Know So Far - ?Vaccine
Efficiency against New Strains?
With New Strains Emerging at an Alarming Rate, Focus Shifts to
Booster Doses & Vaccine Tweaking. But How Practical Is It to
Implement Them?
EXHIBIT 2: With Vaccinated Population Showing Signs of
Declining Clinical Protection, Booster Doses Are Emerging Into
a Necessity to Restore Vaccine Effectiveness: Number of
Booster Doses Administered Per 100 People by Country as of
December 2021
With IMF Making an Upward Revision of Global GDP for 2022,
Companies Are Bullish About a Continuing Economic Comeback
despite a Prolonging Pandemic
EXHIBIT 3: A Strong Yet Uncertain Recovery Shaped by New
Variants Comes Into Play: World Economic Growth Projections:
(Real GDP, Annual % Change) for 2020 through 2022
Allergy Diagnostics Market Under the Covid Lens
Telemedicine Gains Prominence amid the Pandemic
Global Allergy Diagnostics Market Set to Witness Rapid Growth
With Allergies on the Rise for Whatever Reason Be It Our
Neanderthal Genes or Hygiene Hypothesis or Vitamin D
Hypothesis, the Need for Effective Diagnostics Has Never Been
Greater
EXHIBIT 4: Global Prevalence of Allergies (In Million)
Assay Kits Dominate the Allergy Diagnostics Market
Inhaled Allergens Segment to Witness Fastest Growth
US Dominates the Allergy Diagnostics Market, While China to
Witness the Fastest Growth
Rising Demand for In-Vitro Diagnostic Tests for Allergy Diagnosis
EXHIBIT 5: Global In-Vitro Diagnostics (IVD) Market Revenues:
(in %) by Segment for the Year 2021
EXHIBIT 6: Global In-Vitro Diagnostics (IVD) Market Revenues:
(in %) by Geographic Region for the Year 2021
Allergy Diagnostics - Global Key Competitors Percentage Market
Share in 2022 (E)
EXHIBIT 7: Allergy Diagnostics Competitor Market Share Scenario
Worldwide (in %): 2021
Recent Market Activity
Competitive Market Presence - Strong/Active/Niche/Trivial for
67 Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Development of Effective Allergy Diagnostic Products Cuts Down
on Healthcare Spending
EXHIBIT 8: World Healthcare Expenditure (In US$ Trillion) for
the Years 2017, 2019, 2021 & 2023
EXHIBIT 9: Per Capita Healthcare Expenditure (in $) by Select
Countries for 2018
Labs Embrace Automation and Advanced Allergy Tests for Fast
Turnaround Times
Food Allergies - A Major and Growing Concern
Select Digital Technologies to Provide Help in Managing Food
Allergy
Food Allergies Create Opportunities for Food Allergy Testing
ELISA Gains Lead as Preferred Food Testing Method
Need to Offer Quality Services at Affordable Costs Prompts Labs
to Consider Reagent Rental Agreements
In-Vitro IgE Molecular Diagnostics to Transform Allergy Testing
Market
Macro Array Diagnostics Unveils Allergy Explorer for Allergy
Diagnostics
Rising Alcohol and Drug Abuse Increases Demand for Allergy
Diagnostics
Increasing Cases of Allergies Drive Development of Advanced
Allergy Diagnostics Solutions
Focus on Single and Protein Allergens
IgE Antibody Tests
Allergy Diagnostic Reagents on Microchip
Allergy Diagnosis Moves from Lab-based to Decentralized POC Tests
Patch Test to Experience Healthy Growth
SmartPractice Secures FDA Approval for T.R.U.E. Test(R) Patch
Test for Pediatric Use
Providers of Allergy Diagnostic Services Focus on Vertical
Integration
Allergic Diagnostic Challenges in Patients
Enhanced Access to Allergy Diagnosis Medical Insurance &
Instrument Allowances in the US Widen Market Prospects
EXHIBIT 10: Typical Cost Structure for Allergy Testing
Technological Advancements - Mobile Health Tools for Allergy
Patients
Technological Advancements - Nanotechnology for Allergy
Diagnostics
Application of Nanostructures for In-Vitro Diagnosis of Allergy
Application of Nanostructures in Drug-sIgE Detection
Application of Nanostructures for Detection of Allergen-sIgE
Select Recent Launches in the Allergy Diagnostics Market to
Bolster Market Expansion
EUROIMMUM Develops EUROLINE DPA-Dx Pollen Southern Europe 1
Test for Pollen Allergies
Hycor Biomedical Secures FDA Clearance for NOVEOS Allergy
Testing System
ASI Introduces IVT Allergy(R) 3 Screen Panel for Allergy Skin
Testing
CLA-1(TM) Luminometer In-Vitro Allergy Testing Platform for
Accurate, Reliable Results
Growth Drivers
Increasing Prevalence and Incidence of Allergic Disorders to
Drive the Demand for Allergy Diagnostics
EXHIBIT 11: Atopic Dermatitis (Eczema) Prevalence Rates among
Global Adult Population
Environmental Changes and Pollution Aggravate Incidence of
Allergic Reactions, Resulting in Increased Need for Allergy
Diagnostics
Major Environmental Factors with Link to Allergic Diseases
Growing Number of Food Allergy Cases Fuels Demand for Allergy
Testing Kits
EXHIBIT 12: Prevalence Rate of Five Common Food Allergies among
US Adults
Factors Responsible for Rising Prevalence of Food Allergy
Burgeoning Aging Population and Longer Life Expectancy to Drive
Allergy Diagnostics Market
EXHIBIT 13: Global Population Statistics for the 65+ Age Group
in Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
Market Restraints
Inadequate Knowledge about Food Allergy Inhibits Growth of
Allergy Diagnostic Market
Expensive Nature of Allergy Diagnostics Approaches Limits
Market Growth
New Regulations and Statutory Provisions to Affect Diagnostic
Allergen Extracts

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Allergy Diagnostics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Allergy Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Allergy Diagnostics by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for Assay
Kits by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Assay Kits by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 6: World 15-Year Perspective for Assay Kits by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 9: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 12: World 15-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for
Inhaled Allergens by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Inhaled Allergens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Inhaled Allergens by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for Food
Allergens by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Food Allergens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Food Allergens by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for Drug
Allergens by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Drug Allergens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Drug Allergens by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Other Allergens by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Other Allergens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Other Allergens by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 27: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 28: World Recent Past, Current & Future Analysis for
Diagnostic Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Diagnostic Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Diagnostic Laboratories
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2012, 2021 & 2027

Table 31: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 32: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Allergy Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Allergy Prevalence Statistics
Incidences of Food Allergy and Intolerance on the Rise among
Americans
Pain Killer Abuse Leads to High Incidence of Drug Allergy
Reactions
US Witnesses Increasing Popularity of At-Home Allergy
Diagnostic Kits
US Offers Favorable Reimbursements for Allergy Testing
Market Analytics
Table 34: USA Recent Past, Current & Future Analysis for
Allergy Diagnostics by Product - Assay Kits, Instruments and
Services - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 36: USA 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Revenues for Assay
Kits, Instruments and Services for the Years 2012, 2021 & 2027

Table 37: USA Recent Past, Current & Future Analysis for
Allergy Diagnostics by Allergens - Inhaled Allergens, Food
Allergens, Drug Allergens and Other Allergens - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 38: USA Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Revenues for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2021 & 2027

Table 40: USA Recent Past, Current & Future Analysis for
Allergy Diagnostics by End-Use - Hospitals, Diagnostic
Laboratories and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 41: USA Historic Review for Allergy Diagnostics by
End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Revenues for Hospitals,
Diagnostic Laboratories and Other End-Uses for the Years 2012,
2021 & 2027

CANADA
Table 43: Canada Recent Past, Current & Future Analysis for
Allergy Diagnostics by Product - Assay Kits, Instruments and
Services - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 44: Canada Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Revenues for Assay
Kits, Instruments and Services for the Years 2012, 2021 & 2027

Table 46: Canada Recent Past, Current & Future Analysis for
Allergy Diagnostics by Allergens - Inhaled Allergens, Food
Allergens, Drug Allergens and Other Allergens - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 47: Canada Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Revenues for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2021 & 2027

Table 49: Canada Recent Past, Current & Future Analysis for
Allergy Diagnostics by End-Use - Hospitals, Diagnostic
Laboratories and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: Canada Historic Review for Allergy Diagnostics by
End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Revenues for Hospitals,
Diagnostic Laboratories and Other End-Uses for the Years 2012,
2021 & 2027

JAPAN
Table 52: Japan Recent Past, Current & Future Analysis for
Allergy Diagnostics by Product - Assay Kits, Instruments and
Services - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Revenues for Assay
Kits, Instruments and Services for the Years 2012, 2021 & 2027

Table 55: Japan Recent Past, Current & Future Analysis for
Allergy Diagnostics by Allergens - Inhaled Allergens, Food
Allergens, Drug Allergens and Other Allergens - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 56: Japan Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Revenues for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2021 & 2027

Table 58: Japan Recent Past, Current & Future Analysis for
Allergy Diagnostics by End-Use - Hospitals, Diagnostic
Laboratories and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: Japan Historic Review for Allergy Diagnostics by
End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Revenues for Hospitals,
Diagnostic Laboratories and Other End-Uses for the Years 2012,
2021 & 2027

CHINA
Table 61: China Recent Past, Current & Future Analysis for
Allergy Diagnostics by Product - Assay Kits, Instruments and
Services - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 62: China Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Revenues for Assay
Kits, Instruments and Services for the Years 2012, 2021 & 2027

Table 64: China Recent Past, Current & Future Analysis for
Allergy Diagnostics by Allergens - Inhaled Allergens, Food
Allergens, Drug Allergens and Other Allergens - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 65: China Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Revenues for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2021 & 2027

Table 67: China Recent Past, Current & Future Analysis for
Allergy Diagnostics by End-Use - Hospitals, Diagnostic
Laboratories and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: China Historic Review for Allergy Diagnostics by
End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Revenues for Hospitals,
Diagnostic Laboratories and Other End-Uses for the Years 2012,
2021 & 2027

EUROPE
Allergy Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Food Allergy: Regulatory Overview
EU FIC Regulation
Soy Allergy Regulations
Egg Allergy Regulations
Market Analytics
Table 70: Europe Recent Past, Current & Future Analysis for
Allergy Diagnostics by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Allergy Diagnostics by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Allergy Diagnostics by
Geographic Region - Percentage Breakdown of Value Revenues for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027

Table 73: Europe Recent Past, Current & Future Analysis for
Allergy Diagnostics by Product - Assay Kits, Instruments and
Services - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Revenues for Assay
Kits, Instruments and Services for the Years 2012, 2021 & 2027

Table 76: Europe Recent Past, Current & Future Analysis for
Allergy Diagnostics by Allergens - Inhaled Allergens, Food
Allergens, Drug Allergens and Other Allergens - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 77: Europe Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Revenues for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2021 & 2027

Table 79: Europe Recent Past, Current & Future Analysis for
Allergy Diagnostics by End-Use - Hospitals, Diagnostic
Laboratories and Other End-Uses - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: Europe Historic Review for Allergy Diagnostics by
End-Use - Hospitals, Diagnostic Laboratories and Other End-Uses
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Revenues for Hospitals,
Diagnostic Laboratories and Other End-Uses for the Years 2012,
2021 & 2027

FRANCE
Table 82: France Recent Past, Current & Future Analysis for
Allergy Diagnostics by Product - Assay Kits, Instruments and
Services - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 83: France Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Revenues for Assay
Kits, Instruments and Services for the Years 2012, 2021 & 2027

Table 85: France Recent Past, Current & Future Analysis for
Allergy Diagnostics by Allergens - Inhaled Allergens, Food
Allergens, Drug Allergens and Other Allergens - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 86: France Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Revenues for Inhaled

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05797875/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001